GURUFOCUS.COM » STOCK LIST » USA » NAS » Align Technology Inc (NAS:ALGN) » Definitions » Risk Assessment
Switch to:

Align Technology (NAS:ALGN) Risk Assessment

View and export this data going back to 2001. Start your Free Trial

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Align Technology is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison

For the Medical Devices subindustry, Align Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Align Technology Risk Assessment Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Align Technology's Risk Assessment falls in comparison to its industry or sector. The grey bar indicates the Risk Assessment's extreme value range as defined by GuruFocus.

Align Technology  (NAS:ALGN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Align Technology Risk Assessment Related Terms

Thank you for viewing the detailed overview of Align Technology's Risk Assessment provided by Please click on the following links to see related term pages.

Align Technology (NAS:ALGN) Business Description

Align Technology logo
410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Anne Myong director 2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Susan E Siegel director 3000 SAND HILL ROAD, BLDG 3 STE 290, MENLO PARK CA 94025
Markus Christof Sebastian officer: SVP & Mng Dir EMEA 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Pudipeddi Vamsi Mohan Raj officer: SVP, Chief Marketing Officer 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Julie Ann Coletti officer: SVP, Chief Legal & Regulatory 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Joseph Lacob director 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked officer: SVP and Mgng Director, Itero C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Lynn Pendergrass officer: VP, Americas 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Stuart A Hockridge officer: VP, Global Human Resources C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
John Morici officer: Chief Financial Officer C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Sreelakshmi Kolli officer: VP, Info Technology C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Jennifer Olson officer: VP& Mng Dir. D-DCC C/O ALIGN TECHNOLOGY, INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Jennifer Erfurth officer: VP, Global HR C/O ALIGN TECHNOLOGY, INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95131